The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.
Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques
Open accessAbstract
BACKGROUND: The identification of patients with high-risk atherosclerotic plaques prior to the manifestation of clinical events remains challenging. Recent findings question histology- and imaging-based definitions of the "vulnerable plaque," necessitating an improved approach for predicting onset of symptoms. METHODS: We performed a proteomics comparison of the vascular extracellular matrix and associated molecules in human carotid endarterectomy specimens from 6 symptomatic versus 6 asymptomatic patients to identify a protein signature for high-risk atherosclerotic plaques. Proteomics data were integrated with gene expression profiling of 121 carotid endarterectomies and an analysis of protein secretion by lipid-loaded human vascular smooth muscle cells. Finally, epidemiological validation of candidate biomarkers was performed in two community-based studies. RESULTS: Proteomics and at least one of the other two approaches identified a molecular signature of plaques from symptomatic patients that comprised matrix metalloproteinase 9, chitinase 3-like-1, S100 calcium binding protein A8 (S100A8), S100A9, cathepsin B, fibronectin, and galectin-3-binding protein. Biomarker candidates measured in 685 subjects in the Bruneck study were associated with progression to advanced atherosclerosis and incidence of cardiovascular disease over a 10-year follow-up period. A 4-biomarker signature (matrix metalloproteinase 9, S100A8/S100A9, cathepsin D, and galectin-3-binding protein) improved risk prediction and was successfully replicated in an independent cohort, the SAPHIR study. CONCLUSION: The identified 4-biomarker signature may improve risk prediction and diagnostics for the management of cardiovascular disease. Further, our study highlights the strength of tissue-based proteomics for biomarker discovery. FUNDING: UK: British Heart Foundation (BHF); King's BHF Center; and the National Institute for Health Research Biomedical Research Center based at Guy's and St Thomas' NHS Foundation Trust and King's College London in partnership with King's College Hospital. Austria: Federal Ministry for Transport, Innovation and Technology (BMVIT); Federal Ministry of Science, Research and Economy (BMWFW); Wirtschaftsagentur Wien; and Standortagentur Tirol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Proteomic studies have also addressed the kilometres of vascular beds and extracellular matrix responsible for transporting blood, giving valuable insights into the molecular anatomy of aneurysms and atherosclerosis126,127.”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [127]
Experimental — accuracy not yet measuredIn the citing paper
“Further evidence that VSMCs are the major source of collagens comes from studies in vitro , including proteomic analysis of the secretome of lipid-loaded VSMCs 109 and induction of collagen synthesis by VSMCs in culture by TGFβ , PDGF, IL-1, AngII, cholesterol, homocysteine and mechanical stretch 144,145”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c30fb2 · Cited by 5,170
Keller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830
A Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367
Cited by
Vascular smooth muscle cells in atherosclerosis
Basatemur, G. L., Jørgensen, H. F., Clarke, M. C. H., Bennett, M. R., & Mallat, Z. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0227-9 · Cited by 1,099
Targeting inflammation in atherosclerosis — from experimental insights to the clinic
Soehnlein, O., & Libby, P. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00198-1 · Cited by 1,019
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
Vascular smooth muscle cells in atherosclerosis: time for a re-assessment
Grootaert, M. O. J., & Bennett, M. R. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab046 · Cited by 509
Rakipovski, G., Rolin, B., Nøhr, J., Klewe, I., Frederiksen, K. S., Augustin, R., Hecksher-Sørensen, J., Ingvorsen, C., Polex-Wolf, J., & Knudsen, L. B. (2018) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2018.09.004 · Cited by 509
Metadata
- Authors
- Langley, S. R., Willeit, K., Didangelos, A., Matic, L. P., Skroblin, P., Barallobre-Barreiro, J., Lengquist, M., Rungger, G., Kapustin, A., Kedenko, L., Molenaar, C., Lu, R., Barwari, T., Suna, G., Yin, X., Iglseder, B., Paulweber, B., Willeit, P., Shalhoub, J., Pasterkamp, G., Davies, A. H., Monaco, C., Hedin, U., Shanahan, C. M., Willeit, J., Kiechl, S., & Mayr, M.
- Affiliations
- King's College London (GB)
- Innsbruck Medical University (AT)
- Karolinska Institutet (SE)
- Krankenhaus Bruneck (IT)
- Paracelsus Medical University (AT)
- Imperial College London (GB)
- University Medical Center Utrecht (NL)
- University of Oxford (GB)
- Corresponding author
- Mayr, Manuel
- ORCID
- Langley, Sarah R.
- Willeit, Karin
- Didangelos, Athanasios
- Matic, Ljubica Perisic
- Skroblin, Philipp
- Kapustin, Alexander
- Kedenko, Ludmilla
- Molenaar, Chris
- Barwari, Temo
- Suna, Gonca
- Yin, Xiaoke
- Iglseder, Bernhard
- Paulweber, Bernhard
- Willeit, Peter
- Shalhoub, Joseph
- Pasterkamp, Gerard
- Davies, Alun H.
- Monaco, Claudia
- Hedin, Ulf
- Shanahan, Catherine M.
- Willeit, Johann
- Kiechl, Stefan
- Mayr, Manuel
- Venue
- Journal of Clinical Investigation
- Published
- 2017-03-20
- Volume
- 127
- Issue
- 4
- Pages
- 1546-1560
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5373893
- OpenAlex
- W2595645464
- Cited by
- 174
- References
- 85
- Citations by year
- 2026: 20 · 2025: 16 · 2024: 26 · 2023: 17 · 2022: 20 · 2021: 18 · 2020: 20 · 2019: 13 · 2018: 13 · 2017: 11
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Figshare (submittedVersion, cc-by)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- National Institute for Health and Care Research
- British Heart Foundation (FS/13/2/29892, PG/11/46/28979, RG/17/2/32808, CH/16/3/32406, RG/16/14/32397, RG/11/14/29056)
- King's College London
- European Commission
- Austrian Science Fund (J-3679-B13)
- Bundesministerium für Wissenschaft, Forschung und Wirtschaft
- Svenska Sällskapet för Medicinsk Forskning
- Karolinska Institutet
- Stockholms Läns Landsting (ALF‐2011‐0279, ALF‐2011‐0260, ALF2011-0260 and ALF-2011-0279)
- Vetenskapsrådet (349-2007-8703, K2013-65X-06816-30-4, K2009-65X-2233-01-3)
- Österreichische Forschungsförderungsgesellschaft (843536, K-Project Nr. 843536)
- Bundesministerium für Verkehr, Innovation und Technologie
- Novo Nordisk Fonden (NNF15SA0018346)
- Standortagentur Tirol
- Wirtschaftsagentur Wien
- Provincia autonoma di Bolzano - Alto Adige
- Menzies Centre for Australian Studies, King's College London, University of London
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- carotid plaque, vulnerable plaque, biomarker signatures, symptomatic carotid disease, MMP-9, S100A8/S100A9, cathepsin D, LGALS3BP, YKL-40, fibronectin, vascular smooth muscle cells, carotid endarterectomy, cardiovascular risk prediction, Bruneck Study
- MeSH terms
- Carotid Artery Diseases, Cells, Cultured, Extracellular Matrix, Female, Humans, Male, Biomarkers, Extracellular Matrix Proteins, Endarterectomy, Carotid, Proteome, Myocytes, Smooth Muscle, Proteomics, Atherosclerosis, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques. https://app.cochat.ai/papers/10.1172/jci86924
- The paper
- Langley, S. R., Willeit, K., Didangelos, A., Matic, L. P., Skroblin, P., Barallobre-Barreiro, J., Lengquist, M., Rungger, G., Kapustin, A., Kedenko, L., Molenaar, C., Lu, R., Barwari, T., Suna, G., Yin, X., Iglseder, B., Paulweber, B., Willeit, P., Shalhoub, J., . . . Mayr, M. (2017). Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques. Journal of Clinical Investigation. https://doi.org/10.1172/jci86924
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.